Skip to content

Jesus Montero-Marin

Teaching, Research & Innovation Unit, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.

6 papers in the library · 57 citations · publishing 2023-2026

Papers

Pathways to mental well-being for graduates of mindfulness-based cognitive therapy (MBCT) and mindfulness-based stress reduction (MBSR): A mediation analysis of an RCT.

Psychotherapy research : journal of the Society for Psychotherapy Research November 1, 2024 Shannon Maloney, Jesus Montero-Marin, Willem Kuyken 17 citations

Mindfulness-Based Cognitive Therapy-'Taking it Further' (MBCT-TiF) improved mental well-being more than ongoing mindfulness practice alone in 164 graduates of mindfulness-based programs. This improvement occurred through increases in mindfulness, self-compassion, and decentering—each independently mediated the effect. For depression, all three mediators also played a role, but only mindfulness and decentering mediated effects on psychological quality of life and anxiety. The findings suggest that MBCT-TiF works by enhancing these three psychological skills, though future research should test them together and alongside other potential mediators like equanimity.

Target mechanisms of mindfulness-based programmes and practices: a scoping review.

BMJ mental health August 24, 2024 Shannon Maloney, Merle Kock, Yasmijn Slaghekke et al. 16 citations

A systematic review of 27 randomized controlled trials found that mindfulness skills, decentering, and attitudes such as self-compassion are significant indirect pathways through which mindfulness-based programs improve mental health and well-being. Only four studies examined mechanisms within specific mindfulness practices. The evidence for alternative mechanisms like attention and awareness remains limited, especially regarding well-being outcomes, mental health promotion, and comparisons with active controls. The authors call for high-quality trials with powered multivariate mediation analyses to address these knowledge gaps and guide future interventions.

Does mindfulness-based cognitive therapy with tapering support reduce risk of relapse/recurrence in major depressive disorder by enhancing positive affect? A secondary analysis of the PREVENT trial.

Journal of consulting and clinical psychology September 1, 2024 Barnaby D Dunn, Laura Warbrick, Rachel Hayes et al. 10 citations

Mindfulness-based cognitive therapy with support to taper medication (MBCT-TS) increases positive affect more than continuing antidepressant medication alone, and this increase partly explains the reduced risk of relapse or recurrence in people with recurrent depression. In a randomized trial of 424 adults with three or more prior depressive episodes, MBCT-TS led to significantly greater positive affect at posttreatment compared with maintenance antidepressants. Across both treatments, higher positive affect at intake predicted a lower hazard of relapse over two years. Among participants who had not relapsed by posttreatment, a greater rise in positive affect mediated a reduced risk of subsequent relapse. The findings indicate that boosting positive affect is one mechanism through which MBCT-TS protects against relapse when discontinuing antidepressants.

The State- and Trait-Level Effects and Candidate Mechanisms of Four Mindfulness-Based Cognitive Therapy (MBCT) Practices: Two Exploratory Studies.

Mindfulness January 1, 2023 Shannon Maloney, Christina Surawy, Maryanne Martin et al. 9 citations

Four specific mindfulness practices from Mindfulness-Based Cognitive Therapy (body scan, mindful movement, breath and body, and befriending) produced similar state- and trait-level improvements in self-compassion, mindfulness, decentering, interoceptive awareness, and psychological quality of life among 160 adults from the general population. After a single session, state-level effects were observed across all candidate mechanisms and outcomes except decentering, with effect sizes ranging from 0.27 to 0.86. After two weeks of daily practice, trait-level improvements occurred in psychological quality of life and most mechanisms (effect sizes 0.26 to 0.64). No practice proved superior to any other. Changes in mindfulness, self-compassion, decentering, and body listening were linked to better psychological quality of life and more self-led practice.

Examining what works for whom and how in mindfulness-based cognitive therapy (MBCT) for recurrent depression: moderated-mediation analysis in the PREVENT trial.

The British journal of psychiatry : the journal of mental science April 1, 2025 Jesus Montero-Marin, Verena Hinze, Shannon Maloney et al. 4 citations

Mindfulness skills mediate the effect of mindfulness-based cognitive therapy (MBCT) on depressive symptoms over 24 months, and this mediation is stronger for people with more severe depression. Among 424 adults with recurrent depression, those with higher severity showed an expected 10-point reduction on the Beck Depression Inventory-II, compared to a 3.5-point reduction for those with lower severity. The findings suggest MBCT with antidepressant tapering support works through a unique mechanism—mindfulness skills—that differs from maintenance medication alone, supporting personalized treatment for recurrent depression.

Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis

Psychotherapy and Psychosomatics June 12, 2026 Thorsten Barnhofer, Maria Niemi, Johannes Michalak et al. 1 citation

For adults with difficult-to-treat depression—those who have not responded to prior treatments, have treatment-resistant depression, or have a chronic course—mindfulness-based cognitive therapy (MBCT) is likely superior to usual care, reducing depressive symptoms by a standardized mean difference of -0.40 at post-treatment and -0.41 at medium-term follow-up. There was a 92% and 85% probability, respectively, that these benefits exceeded a minimal important difference. However, MBCT did not show clear superiority over other active psychosocial interventions, and no robust moderators of outcome were identified across baseline severity, chronicity, or comorbidity.